Sutro Biopharma Promotes Trevor Hallam, Ph.D., to President of Research and Chief Scientific Officer
Share this article Share this article SOUTH SAN FRANCISCO, Calif., April 20, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced the promotion of Chief Scientific Officer Trevor Hallam, Ph.D., to President of Research. Dr. Hallam will also continue his role as Chief Scientific Officer. "Since joining Sutro as CSO more than 10 years ago, Trevor has been instrume...
Source: prnewswire.com